Ensysce Biosciences (ENSCW) Enterprise Value (2017 - 2025)
Ensysce Biosciences (ENSCW) reported Enterprise Value of -$4.6 million for Q4 2025, down 21.11% year-over-year from -$5.9 million in Q4 2024, and down 131.75% quarter-over-quarter from -$2.0 million in Q3 2025.
Ensysce Biosciences (ENSCW) Enterprise Value (2017 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 9 years of Enterprise Value data on file, last reported at -$4.6 million in Q4 2025.
- Enterprise Value for Q4 2025 came in at -$4.6 million, down 21.11% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.6 million (down 21.11% YoY), and the FY2025 annual result was -$4.6 million, down 21.11% from the prior year.
- Enterprise Value eased to -$4.6 million in Q4 2025 per ENSCW's latest filing, from -$2.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$1.4 million in Q2 2024 and troughed at -$12.5 million in Q4 2021.
- A 5-year average of -$4.9 million and a median of -$3.8 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2023: Enterprise Value tumbled 11413.21% in 2021, then jumped 80.11% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$12.5 million in 2021, then jumped by 72.4% to -$3.5 million in 2022, then jumped by 58.07% to -$1.5 million in 2023, then tumbled by 163.81% to -$3.8 million in 2024, then retreated by 21.11% to -$4.6 million in 2025.
- Business Quant data shows ENSCW's Enterprise Value at -$4.6 million in Q4 2025, -$2.0 million in Q3 2025, and -$2.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Ensysce Biosciences | - | - | - | -4.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.64 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | -2.54 Mn |
| Mar 31, 2025 | -3.38 Mn |
| Dec 31, 2024 | -3.83 Mn |
| Sep 30, 2024 | -4.48 Mn |
| Jun 30, 2024 | -1.37 Mn |
| Mar 31, 2024 | -3.73 Mn |
| Dec 31, 2023 | -1.45 Mn |
| Sep 30, 2023 | -1.79 Mn |
| Jun 30, 2023 | -4.16 Mn |
| Mar 31, 2023 | -1.73 Mn |
| Dec 31, 2022 | -3.46 Mn |
| Sep 30, 2022 | -4.83 Mn |
| Jun 30, 2022 | -12.40 Mn |
| Mar 31, 2022 | -8.72 Mn |
| Dec 31, 2021 | -12.54 Mn |
| Sep 30, 2021 | -7.13 Mn |
| Jun 30, 2021 | -8.26 Mn |
| Dec 31, 2020 | -411,839.00 |